showed that Berbamine (BBM), a marketing drug for treatment of leukopenia in China, obviously inhibited the activity of RAB8A GTPase in an obesity mouse model [56], indicating the variable activity of RAB8A in different diseases. The gene discussed is RAB8A; the disease is Obesity.